Editas Medicine (EDIT) Tops Q2 EPS by 2c

Editas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'